LYRCX | VMVAX | LYRCX / VMVAX | |
Total Expense Ratio | 1.99 | 0.07 | 2,843% |
Annual Report Gross Expense Ratio | 2.46 | 0.07 | 3,514% |
Fund Existence | 3 years | 14 years | - |
Gain YTD | 8.955 | 1.148 | 780% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.05B | 29.9B | 4% |
Annual Yield % from dividends | 0.00 | 2.31 | - |
Returns for 1 year | 15.86 | 8.49 | 187% |
Returns for 3 years | N/A | 26.45 | - |
Returns for 5 years | N/A | 71.21 | - |
Returns for 10 years | N/A | 80.90 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MMCA | 21.18 | -0.02 | -0.10% |
NYLI MacKay California Muni Intmdt ETF | |||
CGV | 13.61 | -0.08 | -0.57% |
Conductor Global Equity Value ETF | |||
INCO | 63.13 | -0.95 | -1.48% |
Columbia India Consumer ETF | |||
EEMA | 80.40 | -1.25 | -1.53% |
iShares MSCI Emerging Markets Asia ETF | |||
VTWO | 84.43 | -1.57 | -1.83% |
Vanguard Russell 2000 ETF |